Susan K Paulson Selected Research

delafloxacin

1/2018	Clinical Pharmacokinetics of Sulfobutylether-β-Cyclodextrin in Patients With Varying Degrees of Renal Impairment.
1/2018	Pharmacokinetics of Intravenous Delafloxacin in Patients With End-Stage Renal Disease.
1/2018	Delafloxacin Pharmacokinetics in Subjects With Varying Degrees of Renal Function.
6/2017	The Pharmacokinetics of the CYP3A Substrate Midazolam After Steady-state Dosing of Delafloxacin.
1/2017	Clinical Pharmacology of Delafloxacin in Patients With Hepatic Impairment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Susan K Paulson Research Topics

Disease

2	Anemia 01/2022 - 01/2021
2	Hypoxia (Hypoxemia) 01/2022 - 01/2021
2	Chronic Renal Insufficiency 01/2022 - 01/2021
2	Chronic Kidney Failure (Chronic Renal Failure) 01/2018 - 01/2018
2	Infections 06/2017 - 01/2017
2	Crohn Disease (Crohn's Disease) 05/2013 - 03/2012
1	Hyperphosphatemia 01/2022
1	Diarrhea 01/2018
1	Renal Insufficiency (Renal Failure) 01/2018
1	Pneumonia (Pneumonitis) 01/2017

Drug/Important Bio-Agent (IBA)

5	delafloxacinIBA 01/2018 - 01/2017
2	vadadustatIBA 01/2022 - 01/2021
2	Prolyl-Hydroxylase InhibitorsIBA 01/2022 - 01/2021
2	FluoroquinolonesIBA 01/2018 - 06/2017
2	Adalimumab (Humira)FDA Link 05/2013 - 03/2012
1	Phosphates (Orthophosphate)IBA 01/2022
1	IronIBA 01/2022
1	CreatinineIBA 01/2018
1	Pharmaceutical PreparationsIBA 05/2013
1	C-Reactive ProteinIBA 05/2013
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2013

Therapy/Procedure

2	Renal Dialysis (Hemodialysis) 01/2018 - 01/2018
1	Intravenous Infusions 01/2018
1	Therapeutics 05/2013